Home/Filings/4/0001638599-19-000654
4//SEC Filing

LaBelle Curt H 4

Accession 0001638599-19-000654

CIK 0001682639other

Filed

Jul 14, 8:00 PM ET

Accepted

Jul 15, 5:46 PM ET

Size

10.4 KB

Accession

0001638599-19-000654

Insider Transaction Report

Form 4
Period: 2019-07-11
LaBelle Curt H
Director10% Owner
Transactions
  • Purchase

    Common Stock, par value $.0001

    2019-07-11$2.78/sh+17,985$49,99827,985 total
Holdings
  • Common Stock, par value $.0001

    (indirect: By Private Medical Equity, Inc.)
    606,667
  • Common Stock, par value $.0001

    (indirect: By LLC)
    453,333
  • Stock Option (right to buy)

    Exercise: $1.95Exp: 2027-07-07Common Stock (133,334 underlying)
    133,334
  • Stock Option (right to buy)

    Exercise: $1.24From: 2015-03-02Exp: 2025-03-02Common Stock (40,000 underlying)
    40,000
  • Stock Option (right to buy)

    (indirect: By Private Medical Equity, Inc.)
    Exercise: $1.24From: 2015-03-23Exp: 2025-03-23Common Stock (140,000 underlying)
    140,000
Footnotes (2)
  • [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F2]The option became exercisable as to 3,704 shares on August 7, 2017, and becomes exercisable in equal 3,704 share amounts on each of the 35 one-month anniversaries thereafter.

Issuer

EYENOVIA, INC.

CIK 0001682639

Entity typeother

Related Parties

1
  • filerCIK 0001396235

Filing Metadata

Form type
4
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 5:46 PM ET
Size
10.4 KB